UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism

Circulation (New York, N.Y.), 2017-01, Vol.135 (4), p.338-351

2017

Volltextzugriff (PDF)

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Clinical science (1979), 2008-05, Vol.114 (10), p.611-624

2008

Volltextzugriff (PDF)

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

Diabetes care, 2010-05, Vol.33 (5), p.1134-1139

2010

Volltextzugriff (PDF)

Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome

The journal of clinical endocrinology and metabolism, 2014-11, Vol.99 (11), p.E2335-E2340

2014

Volltextzugriff (PDF)

Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)

Metabolism, clinical and experimental, 2016-04, Vol.65 (4), p.381-390

2016

Volltextzugriff (PDF)

Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus

Arteriosclerosis, thrombosis, and vascular biology, 2014-02, Vol.34 (2), p.427-432

2014

Volltextzugriff (PDF)

Lipid Disorders and Mutations in the APOB Gene

Clinical chemistry (Baltimore, Md.), 2004-10, Vol.50 (10), p.1725-1732

2004

Volltextzugriff (PDF)

Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels

Diabetes care, 2007-11, Vol.30 (11), p.2945-2950

2007

Volltextzugriff (PDF)

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

Journal of lipid research, 2011-04, Vol.52 (4), p.794-800

2011

Volltextzugriff (PDF)

molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin

Journal of lipid research, 2007-03, Vol.48 (3), p.699-708

2007

Volltextzugriff (PDF)

Plasma Proprotein Convertase Subtilisin/Kexin Type 9: A Marker of LDL Apolipoprotein B-100 Catabolism?

Clinical chemistry (Baltimore, Md.), 2009-11, Vol.55 (11), p.2049-2052

2009

Volltextzugriff (PDF)

Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men

The journal of clinical endocrinology and metabolism, 2009-03, Vol.94 (3), p.989-997

2009

Volltextzugriff (PDF)

Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome

Diabetes (New York, N.Y.), 2003-03, Vol.52 (3), p.803-811

2003

Volltextzugriff (PDF)

Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient ( LDLR +/- and LDLR -/- ) Yucatan Miniature Pigs

Arteriosclerosis, thrombosis, and vascular biology, 2018-05, Vol.38 (5), p.1178-1190

2018

Volltextzugriff (PDF)

Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin

Journal of lipid research, 2017-07, Vol.58 (7), p.1315-1324

2017

Volltextzugriff (PDF)

Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update

Nutrients, 2015-06, Vol.7 (6), p.4416-4425

2015

Volltextzugriff (PDF)

Apolipoprotein B-100 and ApoA-II Kinetics as Determinants of Cellular Cholesterol Efflux

The journal of clinical endocrinology and metabolism, 2012-09, Vol.97 (9), p.E1658-E1666

2012

Volltextzugriff (PDF)

Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus

Arteriosclerosis, thrombosis, and vascular biology, 2015-12, Vol.35 (12), p.2686-2693

2015

Volltextzugriff (PDF)

Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women

Arteriosclerosis, thrombosis, and vascular biology, 2008-10, Vol.28 (10), p.1838-1843

2008

Volltextzugriff (PDF)

Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque

Atherosclerosis, 2018-08, Vol.275, p.232-238

2018

Volltextzugriff (PDF)

Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor

Journal of lipid research, 2008-10, Vol.49 (10), p.2218-2229

2008

Volltextzugriff (PDF)

ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia

The journal of clinical endocrinology and metabolism, 2016-10, Vol.101 (10), p.3732-3739

2016

Volltextzugriff (PDF)

Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism

Journal of lipid research, 2007-08, Vol.48 (8), p.1746-1753

2007

Volltextzugriff (PDF)

Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function

Atherosclerosis, 2014-01, Vol.232 (1), p.211-216

2014

Volltextzugriff (PDF)

Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis development

European journal of endocrinology, 2017-08, Vol.177 (2), p.137-143

2017

Volltextzugriff (PDF)

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(248)
Mit Volltextzugriff
(191)

Publikationsform

Artikel
(255)
Berichte
(1)

Sprache

Englisch
(255)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein Metabolism

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome

Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)

Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus

Lipid Disorders and Mutations in the APOB Gene

Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels

Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease

molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin

Plasma Proprotein Convertase Subtilisin/Kexin Type 9: A Marker of LDL Apolipoprotein B-100 Catabolism?

Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men

Differential Regulation of Lipoprotein Kinetics by Atorvastatin and Fenofibrate in Subjects With the Metabolic Syndrome

Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient ( LDLR +/- and LDLR -/- ) Yucatan Miniature Pigs

Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin

Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update

Apolipoprotein B-100 and ApoA-II Kinetics as Determinants of Cellular Cholesterol Efflux

Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus

Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women

Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque

Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor

ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia

Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism

Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function

Tamoxifen reduces hepatic VLDL production and GH secretion in women: a possible mechanism for steatosis development

Suchergebnisse filtern